Cargando…
Older adults should not be omitted from inclusion in clinical trials of SARS-CoV-2 vaccines
Autores principales: | Sacco, Guillaume, Célarier, Thomas, Gavazzi, Gaetan, Annweiler, Cédric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537629/ https://www.ncbi.nlm.nih.gov/pubmed/33041157 http://dx.doi.org/10.1016/j.maturitas.2020.10.002 |
Ejemplares similares
-
Should Intercepting Traps Be Omitted?
Publicado: (1912) -
Initial functional disability as a 1-year prognostic factor in geriatric patients hospitalized with SARS-CoV-2 infection
por: Brière, Olivier, et al.
Publicado: (2023) -
National French Survey of Coronavirus Disease (COVID-19) Symptoms in People Aged 70 and Over
por: Annweiler, Cédric, et al.
Publicado: (2020) -
Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65 years: a systematic review
por: Addario, Alexandra, et al.
Publicado: (2023) -
Should we vaccinate children against SARS-CoV-2?
por: The Lancet Infectious Diseases
Publicado: (2021)